THE STRANGE STORY OF CLOZAPINE - COMMENT

被引:14
作者
MCKENNA, PJ [1 ]
BAILEY, PE [1 ]
机构
[1] SANDOZ LTD,DEPT CNS,CLIN RES,CH-4002 BASEL,SWITZERLAND
关键词
D O I
10.1192/S0007125000131691
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:32 / 37
页数:6
相关论文
共 38 条
[1]   CLOZAPINE - A NOVEL ANTIPSYCHOTIC AGENT [J].
BABLENIS, E ;
WEBER, SS ;
WAGNER, RL .
DICP-THE ANNALS OF PHARMACOTHERAPY, 1989, 23 (02) :109-115
[2]  
BALDESSARINI RJ, 1988, ARCH GEN PSYCHIAT, V45, P79
[3]  
BALDESSARINI RJ, 1991, NEW ENGL J MED, V324, P746
[4]  
BREIER A, 1987, AM J PSYCHIAT, V144, P1549
[5]   STRIATAL DOPAMINE D2-RECEPTOR BLOCKADE BY TYPICAL AND ATYPICAL NEUROLEPTICS [J].
BRUCKE, T ;
ROTH, J ;
PODREKA, I ;
STROBL, R ;
WENGER, S ;
ASENBAUM, S .
LANCET, 1992, 339 (8791) :497-497
[6]  
COWARDS DM, 1992, J PSYCHIATRY S17, V160, P5
[7]   DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS [J].
CREESE, I ;
BURT, DR ;
SNYDER, SH .
SCIENCE, 1976, 192 (4238) :481-483
[8]  
DAVIS JM, 1985, COMP TXB PSYCHIATRY
[9]  
EKBLOM B, 1974, CURR THER RES CLIN E, V16, P945
[10]   D1-DOPAMINE AND D2-DOPAMINE RECEPTOR OCCUPANCY DURING TREATMENT WITH CONVENTIONAL AND ATYPICAL NEUROLEPTICS [J].
FARDE, L ;
WIESEL, FA ;
NORDSTROM, AL ;
SEDVALL, G .
PSYCHOPHARMACOLOGY, 1989, 99 :S28-S31